Д.Мөнхцэцэг
Loading...
Товч нэр
Д.Мөнхцэцэг
Бүтэн нэр
Даваацэрэн Мөнхцэцэг
Латин нэр
Davaatseren Munkhtsetseg
Албан тушаал
Багш
Эрдмийн цол
Дэд профессор
2 results
Now showing 1 - 2 of 2
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Metabolic Syndrome in Women Who Have Polycystic Ovary Syndrome Related Infertility(Mongolian National University of Medical Sciences, 2021-10-03); Objective: The aim of the present study was to determine the prevalence of metabolic syndrome (MS) in infertile Mongolian women with polycystic ovary syndrome (PCOS) using the International Diabetes Federation (IDF) criteria. Methods: We used the case control retrospective study designs. Total 1340 infertile women enrolled in this study. Among the women, 114 were found with PCOS by Rotterdam’s criteria at the Infertility and reproductive department, National Center for Maternal and Child Health, between December 2018 and 2019. The IDF diagnostic criteria for metabolic syndrome (MS) was used. The PCOS patients were divided into the following groups: (1) cases (with MS, n = 42) and (2) controls (without MS, n = 72). Results: The average age, body mass index (BMI), and duration of infertility were 28.7 ± 4.1 years, 27.3 ± 5.2 kg/m² and 4.4 ± 3.1y, respectively. Among the patients 57.9% of them had oligomenorrhea, 22.8% had amenorrhea, 57.0% had primary infertility, 51.9% had hirsutism and 50.8% had acne. As a result of hormone assays, LH was 9.3±3.5mIU/ml, LH/FSH ratio was 1.6 ± 0.83 [0.1-3.6], and AMH was 6.1ng/ml ± 3.6 [2.9 - 21.0]. The prevalence of MS was 36.8%. The variables which include age (30.9 ± 4.9), body mass (75.9 ± 11.6kg), and also some metabolic parameters such as hypertension (133.6/88.4 ± 13.6 mm Hg), WC (94.1 ± 8.6 cm) and high triglyceride (1.8 ± 1.0 mmol/l) were observed in the MS group and compared to the without MS group. Conclusions: We found out that the prevalence of metabolic syndrome was 36.8% among infertile women with PCOS. Age, BMI, WC, amenorrhea, acne, and acanthosis nigricans were highly related to metabolic syndrome. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Mild Ovarian Stimulation for Infertility in Women with Polycystic Ovary Syndrome(Mongolian National University of Medical Sciences, 2022-04-01); ; Objective: The aim of this study was to explore the effect of clomiphene citrate (CC) on the cycle characteristics and outcomes of women with polycystic ovarian syndrome (PCOS) undergoing ovarian stimulation. Methods: This is a cross sectional study, and it was conducted at the tertiary-care medical center. This study included 55 PCOS patients and 54 patients without PCOS undergoing ovarian mild stimulation. In the study group (n = 55), CC and human menopausal gonadotropin (HMG) were administered simultaneously beginning on cycle day 3, while in the control group without PCOS (n = 54) a differing protocol treatment was used. The primary outcome measure was the stimulation day, HMG dose, number of dominant follicles, serum E2, LH, P4 in trigger day and number of oocytes. Secondary outcomes included the number of top-quality embryos, maturation rate, fertilization rate, cleavage rate, incidence of premature LH surge, and OHSS, biochemical and clinical pregnancy rate. Results: The study group received obviously a lower total HMG dose [470.54 ± 304.5 (375–975) vs. 500.00 ± 287.59 IU, but similar HMG duration. While the antral follicle count (AFC) was higher in the study group, the number of oocytes retrieved and top-quality embryos was remarkably less [5 (0 – 30) vs. 13 (0 – 42), 2 (0 –14) vs. 3.5 (0 – 15), p = 0.003, respectively]. The mature oocyte rate was higher in the study group (p = 0.036). No significant differences were detected in fertilization rate and cleavage rate between the 2 groups. CC had a positive influence (higher oocytes retrieved and top-quality embryos) on cycle characteristics, but might be correlated with the impaired IVF outcomes (lower E2, lower implantation rate) in PCOS patients undergoing IVF, when CC + HMG was used simultaneously. Conclusion: In women with PCOS, mild CC stimulation resulted in increased oocytes and viable embryos compared with the control group. The study regimens had a low incidence of OHSS. The results of the CC combined regimen provide new insights into the development of a more patient-friendly protocol for women with PCOS. However, this study needs to be continued on more samples in the future.